• In early January 2026, President Donald Trump proposed a one-year cap on credit card interest rates at 10%, a move that directly targets a core revenue source for lenders like Synchrony Financial.
• This sudden policy push spotlights Synchrony’s heavy reliance on interest income from credit card balances, raising fresh questions about regulatory risk in its business model.
• Next, we’ll examine how the proposed 10% interest rate cap challenges Synchrony’s prior investment narrative built around digital growth and partnerships.

Find companies with promising cash flow potential yet trading below their fair value.

Synchrony Financial Investment Narrative Recap

To own Synchrony, you need to believe its core credit card and partner financing franchise can keep generating attractive returns despite credit and regulatory pressures, with digital partnerships supporting growth. The proposed one-year 10% rate cap directly targets interest income and has become the key short term swing factor for earnings, amplifying existing concerns about regulatory risk and the resilience of its highly interest dependent business model.

The most relevant recent development here is Synchrony’s 2025 guidance for US$15.2 billion to US$15.7 billion in net revenue, which assumed existing pricing and regulatory conditions. A binding 10% cap on credit card APRs could put that guidance under pressure, at least temporarily, and may also influence how investors weigh previously highlighted growth catalysts such as Amazon and Walmart partnerships against the now more front and center policy risk.

Yet investors should also be aware that tighter rules on APRs could interact with Synchrony’s already elevated bad loan levels and concentrated partner base in ways that...

Synchrony Financial's narrative projects $16.5 billion revenue and $3.3 billion earnings by 2028. This requires 21.7% yearly revenue growth and a modest $0.1 billion earnings increase from $3.2 billion today.

Uncover how Synchrony Financial's forecasts yield a $88.22 fair value, a 11% upside to its current price.

Exploring Other Perspectives

Six members of the Simply Wall St Community currently see fair value for Synchrony between US$57.52 and US$152.24, underlining how far apart individual estimates can be. Against that spread, the new focus on potential APR caps and broader regulatory scrutiny may meaningfully influence how you think about the company’s earnings resilience and long term role in consumer finance, so it is worth weighing several different viewpoints before forming a view.

Explore 6 other fair value estimates on Synchrony Financial - why the stock might be worth as much as 91% more than the current price!

Build Your Own Synchrony Financial Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Synchrony Financial research is our analysis highlighting 5 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Synchrony Financial research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Synchrony Financial's overall financial health at a glance.

Interested In Other Possibilities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Explore 29 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• Uncover the next big thing with financially sound penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.